Xiong, Chengjie
Agboola, Folasade
Luo, Jingqin
Funding for this research was provided by:
National Institutes of Health (P30 AG066444, P01 AG03991, P01 AG026276, R01 AG067505, U19AG071754, U19AG069701)
Article History
Received: 16 May 2025
Accepted: 11 February 2026
First Online: 24 February 2026
Declarations
:
: The Washington University Human Research Protection Office approved the study. Informed consent to participate was obtained from all of the participants in the study. The research was conducted in accordance with the ethical principles of the Declaration of Helsinki.
: Not applicable.
: Work citing NIH grant AG067505 requires an institutional disclosure. Washington University School of Medicine in St. Louis has a financial interest in C2N Diagnostics and may financially benefit if the company is successful in marketing its product(s) that are related to this research.